H.R.5378 — Lower Costs, More Transparency Act
House Roll Call
H.R.5378
| Bill | H.R.5378 — Lower Costs, More Transparency Act |
|---|---|
| Vote question | On Motion to Suspend the Rules and Pass, as Amended |
| Vote type | 2/3 Yea-And-Nay |
| Result | Passed |
| Totals | Yea 320 / Nay 71 / Present 1 / Not Voting 41 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 166 | 40 | 0 | 14 |
| D | 154 | 31 | 1 | 27 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Motion to Suspend the Rules and Pass, as Amended
Bill Analysis
Bill Summary: HR 5378 - Lower Costs, More Transparency Act
The Lower Costs, More Transparency Act (HR 5378) aims to enhance transparency in healthcare pricing and reduce out-of-pocket costs for patients. The bill introduces several key provisions that target prescription drug pricing, insurance coverage, and healthcare provider billing practices.
Key Provisions:
Prescription Drug Pricing Transparency: The bill mandates that pharmaceutical companies disclose the prices of drugs, including any price increases, to the public. This aims to empower consumers with information to make informed choices regarding their medications.
Insurance Coverage Requirements: The legislation requires health insurers to provide clear information about covered services, including cost-sharing details and out-of-pocket maximums. This transparency is designed to help patients understand their financial responsibilities before receiving care.
Provider Billing Practices: The bill establishes guidelines for healthcare providers to ensure that patients receive upfront estimates of the costs associated with their care, reducing unexpected medical bills.
Patient Assistance Programs: HR 5378 allocates funding to support patient assistance programs that help low-income individuals afford necessary medications and treatments, thereby increasing access to essential healthcare services.
Funding and Authorities: The bill authorizes appropriations to relevant federal agencies, including the Department of Health and Human Services (HHS), to implement the transparency measures and support patient assistance initiatives.
Beneficiaries and Regulation: The primary beneficiaries of the Lower Costs, More Transparency Act are patients, particularly those facing high out-of-pocket costs for medications and healthcare services. The bill also impacts pharmaceutical companies, health insurers, and healthcare providers by imposing new transparency requirements and regulations.
Key Timelines: The latest action on HR 5378 was the motion to reconsider, which was laid on the table and agreed to without objection. This indicates that the bill has progressed through initial legislative hurdles, but further actions and timelines for implementation of its provisions will depend on subsequent legislative sessions and appropriations processes.
Yea (320)
C
Colin Allred
K
Kelly Armstrong
J
Jamaal Bowman
L
Larry Bucshon
M
Michael Burgess
C
Cori Bush
K
Ken Calvert
Y
Yadira Caraveo
T
Tony Cárdenas
J
Jerry Carl
L
Lori Chavez-DeRemer
G
Gerald Connolly
A
Anthony D'Esposito
J
John Duarte
J
Jeff Duncan
A
Anna Eshoo
A
A. Ferguson
S
Scott Franklin
M
Matt Gaetz
M
Mike Gallagher
R
Ruben Gallego
J
John Garamendi
M
Mike Garcia
K
Kay Granger
G
Garret Graves
M
Mark Green
R
Raúl Grijalva
J
Jeff Jackson
B
Bill Johnson
D
Derek Kilmer
A
Ann Kuster
D
Doug Lamborn
J
Jake LaTurner
D
Debbie Lesko
B
Blaine Luetkemeyer
L
Lucy McBath
L
Lisa McClain
P
Patrick McHenry
M
Marcus Molinaro
W
Wiley Nickel
D
Donald Payne
M
Mary Peltola
G
Greg Pence
K
Katie Porter
B
Bill Posey
C
Cathy Rodgers
J
John Rutherford
J
John Sarbanes
A
Abigail Spanberger
M
Michelle Steel
E
Eric Swalwell
R
Rashida Tlaib
D
David Trone
N
Nydia Velázquez
M
Michael Waltz
J
Jennifer Wexton
S
Susan Wild
B
Brandon Williams
Nay (71)
D
Dan Bishop
E
Earl Blumenauer
K
Ken Buck
L
Lloyd Doggett
B
Bob Good
D
Daniel Kildee
G
Grace Napolitano
B
Bill Pascrell
M
Matthew Rosendale
D
David Schweikert
P
Pete Sessions
Present (1)
Not Voting (41)
M
Matt Cartwright
J
Jason Crow
B
Brian Higgins
S
Sheila Jackson Lee
B
Barbara Lee
K
Kathy Manning
K
Kevin McCarthy
A
Alexander Mooney
D
Dean Phillips
C
C. Ruppersberger
D
Debbie Wasserman Schultz
B
Brad Wenstrup
